thiazolidinediones protective_against type 2 diabetes

Subject: thiazolidinediones
Relation: protective_against
Object: type 2 diabetes
p-value: —

Evidence from: primary | all sources

Evidence (1 sources)

The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat. (2013) PMID:24285952 cited

PPARγ agonists, thiazolidinediones, are used for the treatment of type 2 diabetes

confidence: 0.96